Teleflex Price Target Cut to $245.00/Share From $275.00 by RBC Capital
Teleflex Is Maintained at Outperform by RBC Capital
Jefferies Adjusts Price Target on Teleflex to $230 From $260
BofA Securities Maintains Teleflex(TFX.US) With Hold Rating
Morgan Stanley Maintains Teleflex(TFX.US) With Buy Rating, Maintains Target Price $275
Raymond James Maintains Teleflex(TFX.US) With Buy Rating, Cuts Target Price to $245
A Quick Look at Today's Ratings for Teleflex(TFX.US), With a Forecast Between $245 to $285
Teleflex Analyst Ratings
RBC Cuts Price Target on Teleflex to $245 From $275
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Raises Target Price to $255
Teleflex Is Maintained at Outperform by RBC Capital
Teleflex Analyst Ratings
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Raises Target Price to $275
BofA Securities Maintains Teleflex(TFX.US) With Hold Rating, Announces Target Price $250
Maintaining Hold on Teleflex Amid Mixed Market Opportunities and Competitive Challenges
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)
Teleflex's Stock Buy Rating: Diverse Portfolio and Strategic Market Advantages Propel Growth
Teleflex Price Target Maintained With a $260.00/Share by RBC Capital
Teleflex Analyst Ratings
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Maintains Target Price $260